← Leaderboards
Eric Miller
University Of California Los Angeles
$944,817
Attributed
$944,817
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$944,817 · 3
By mechanism
M01$829,064 · 2
P20$115,753 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- William M Pardridge$11,519,163
- William Donald Shields$2,905,530
- Jeffrey L. Cummings$25,787,245
- Baljit Khakh$22,550,254
- Elyse J Singer$32,172,584
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchOpportunistic InfectionsHuman Therapy EvaluationAids TherapyDrug Screening /EvaluationHuman SubjectHiv InfectionsCentral Nervous System DisordersChemopreventionDopamine AgonistsAids Dementia ComplexAids /Hiv NeuropathyAmantadineAntiaids AgentAntiparkinson DrugsAntiviral AgentsBrain DisordersHuman Immunodeficiency VirusMicroorganism Disease ChemotherapyNervous System Disorder ChemotherapyNeuromuscular FunctionNeurotrophic FactorsPainPeripheral Nervous System Disorders
Grant awards (5)
INBRE SAN JUAN COLLEGE$115,753
P20 · FY2010 · RR · contact PI
PHASE II, DOUBLE-BLIND TRIAL OF RECOMBINANT HUMAN NERVE GROWTH FACTOR IN HIV INF$207,266
M01 · FY2001 · RR
PHASE II, DOUBLE-BLIND TRIAL OF RECOMBINANT HUMAN NERVE GROWTH FACTOR IN HIV INF$207,266
M01 · FY2001 · RR
PHASE II,RANDOMIZED,DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL OF MEMANTINE FOR AIDS$207,266
M01 · FY2001 · RR
PHASE II,RANDOMIZED,DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL OF MEMANTINE FOR AIDS$207,266
M01 · FY2001 · RR